Drug intelligence / Profile preview

Imunoinstant G

Development stage
Unknown
Lead developer
ROMVAC
Modality
Antibody-Based Therapeutics
Administration
Oral
01

Overview

Imunoinstant G is a dietary supplement developed by the Romanian company Romvac Company under the Imunoinstant brand. It is a lyophilized powder containing polyclonal IgY antibodies (immunoglobulin Y) extracted from the egg yolks of hyperimmunized hens. The product is designed to provide passive immune support by delivering specific antibodies that target and neutralize a broad spectrum of bacterial, viral, and fungal pathogens. By binding to these pathogens, the IgY antibodies prevent their attachment to mucosal surfaces and neutralize their activity, thereby supporting the body's natural defense mechanisms against infections. It is typically administered orally and is marketed for the management and prevention of various infectious conditions.

Brand names
Imunoinstant G
Other names
Imunoinstant G lyophilized powderpolyclonal IgY antibody food supplement

Beyond the preview

Go deeper on Imunoinstant G.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Imunoinstant G.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call